Detalles de la búsqueda
1.
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
J Clin Oncol
; 15(5): 1722-9, 1997 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-9164178
2.
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Bone Marrow Transplant
; 36(10): 901-6, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16151421
3.
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.
Int J Oncol
; 15(3): 511-8, 1999 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10427133
4.
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data.
Hum Pathol
; 25(5): 449-54, 1994 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-8200638
5.
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.
Bone Marrow Transplant
; 14(5): 779-82, 1994 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-7534161
6.
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.
Bone Marrow Transplant
; 8(2): 105-11, 1991 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1933050
7.
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer.
Bone Marrow Transplant
; 20(3): 199-203, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9257887
8.
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation.
Bone Marrow Transplant
; 29(9): 753-7, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12040472
9.
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies.
Bone Marrow Transplant
; 18(3): 495-9, 1996 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-8879608
10.
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation.
Bone Marrow Transplant
; 21 Suppl 3: S92-8, 1998 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9712506
11.
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens.
Bone Marrow Transplant
; 29(11): 881-6, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12080351
12.
Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia.
Leuk Lymphoma
; 41(3-4): 425-8, 2001 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11378557
13.
Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.
Leuk Lymphoma
; 18(1-2): 153-7, 1995 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-8580818
14.
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Leuk Lymphoma
; 31(1-2): 187-94, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9720728
15.
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Eur Cytokine Netw
; 7(3): 395-9, 1996 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-8954183
16.
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer.
Eur Cytokine Netw
; 9(1): 93-8, 1998 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-9613683
17.
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
Anticancer Res
; 21(2B): 1431-7, 2001.
Artículo
en Inglés
| MEDLINE | ID: mdl-11396227
18.
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study.
Anticancer Res
; 20(3B): 2033-40, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-10928147
19.
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]. / Chimiothérapie intensive avec autogreffe de cellules souches hématopoïétiques dans le cancer de l'ovaire: analyse de 67 patientes traitées à l'institut Paoli-Calmettes et revue de la littérature.
Bull Cancer
; 84(9): 869-76, 1997 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-9435808
20.
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Leukemia
; 17(4): 811-3, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12682645